Soluble HLA-G expression and renal graft acceptance

American Journal of Transplantation

Volumn 6, Issue 9, 2006, Pages 2152-2156

  Qiu, J ^a   Terasaki, P I ^a   Miller, J ^b   Mizutani, K ^a   Cai, J ^a   Carosella, E D ^c  

^a TERASAKI FOUNDATION LABORATORY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c Inst Univ d'Hématologie   (France)

Author keywords

HLA antibody; HLA G; Kidney transplantation; Rejection

Indexed keywords

ANTIBODY; CYCLOSPORIN A; HLA ANTIGEN; HLA G ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MINOR HISTOCOMPATIBILITY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN A ANTIBODY; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; BLOOD LEVEL; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; REVIEW;

EID: 33746887042     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01417.x     Document Type: Review

References (31)

1. Kirszenbaum M, Djoulah S, Hors J et al. HLA-G gene polymorphism segregation within CEPH reference families. Hum Immunol 1997; 53: 140-147.
2. Ishitani A, Kishida M, Sageshima N et al. Re-examination of HLA-G polymorphism in African Americans. Immunogenetics 1999; 49: 808-811.
3. Solier C, Aguerre-Girr M, Lenfant F et al. Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur J Immunol 2002; 32: 3576-3586.
4. Yang Y, Chu W, Geraghty DE, Hunt JS. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma. J Immunol 1996; 156: 4224-4231.
5. Moreau P, Adrian-Cabestre F, Menier C et al. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 1999; 11: 803-811.
6. Onno M, Pangault C, Le Friec G, Guilloux V, Andre P, Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: Specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 2000; 164: 6426-6434.
7. Aractingi S, Briand N, Le Danff C et al. HLA-G and NK receptor are expressed in psoriatic skin: A possible pathway for regulating infiltrating T cells? Am J Pathol 2001; 159: 71-77.
8. Nuckel H, Rebmann V, Durig J, Duhrsen U, Grosse-Wilde H.HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood. 2005; 105: 1694-1698.
9. Rouas-Freiss N, Moreau P, Ferrone S, Carosella ED. HLA-G proteins in cancer: Do they provide tumor cells with an escape mechanism? Cancer Res 2005; 65: 10139-10144.
10. Lila N, Carpentier A, Amrein C, Khalil-Daher I, Dausset J, Carosella ED. Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000; 355: 2138.
11. Lila N, Amrein C, Guillemain R et al. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002; 105: 1949-1954.
12. Ciancio G, Contreras N, Esquenazi V et al. Kidney transplantation at the University of Miami. In: Cecka JM, Terasaki PI, eds. Clinical Transplants. Los Angeles: UCLA Immunogenetics Center, 1999: 159-172.
13. Mizutani K, Terasaki P, Rosen A et al. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant. 2005; 5: 2265-2272.
14. Le Rond S, Le Maoult J, Creput C et al. Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: In vivo implications in transplanted patients. Eur J Immunol. 2004; 34: 649-660.
15. Menier C, Saez B, Horejsi V et al. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: New tools to analyze the expression of nonclassical HLA class I molecules. Hum Immunol. 2003; 64: 315-326.
16. Le Bouteiller P. HLA class I chromosomal regin, genes and products: Facts and questions. Crit Rev Immunol 1994; 14: 89-129.
17. Carsella ED, Moreau P, Aractingi S, Rouas-Freiss N. HLA-G: A shield against inflammatory aggression. Trends Immunol 2001; 22: 553-555.
18. Rebmann V, Pfeiffer K, Passler M et al. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 1999; 53: 14-22.
19. Rebmann V, Busemann A, Lindemann M, Grosse-wilde H. Detection of HLA-G5 secreting cells. Hum Immunol 2003; 64: 1017-1024.
20. Rouas-Freiss N, LeMaoult J, Moreau P, Dausset J, Carosella ED. HLA-G in transplantation: A relevant molecule for inhibition of graft rejection? Am J Transplant 2003; 3: 11-16.
21. Carosella ED, Moreau P, Le Maoult J, Le Discorde M, Rouas-Freiss N. HLA-G molecules: From maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003; 81: 199-252.
22. Fournel S, Aguerre-Girr M, Huc X et al. Cutting edge: Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000; 164: 6100-6104.
23. Contini P, Ghio M, Poggi A et al. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003; 33: 125-134.
24. Riteau B, Menier C, Khalil-Daher I et al. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 1999; 43: 203-211.
25. Le Friec G, Laupeze B, Fardel O et al. Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T cell proliferation without altering dendritic differentiation and maturation processes. Hum Immunol 2003; 64: 752-761.
26. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: A CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A 2001; 98: 12150-12155.
27. Creput C, Le Friec G, Bahri R et al. The detection of HLA-G in both serum and graft biopsy is associated with fewer acute rejections following combined liver-kidney transplantation: Possible implications for the monitoring of patients. Hum Immunol 2003; 64: 1064-1072.
28. Moreau P, Faure O, Lefebvre S et al. Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts. Transplant Proc 2001; 33: 2277-2280.
29. Steele DJ, Laufer TM, Smiley ST et al. Two levels of help for B cell alloantibody production. J Exp Med 1996; 183: 699-703.
30. Lumsden JM, Williams JA, Hodes RJ. Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo. J Immunol 2003; 170: 781-787.
31. Terasaki PI, Cai J. Humoral theory of transplantation: Further evidence. Curr Opin Immunol. 2005; 17: 541-545.